Cover Image
市場調查報告書

藥品的凍結乾燥:產品及服務

Lyophilisation for Pharmaceuticals - Products and Services 2015-2025: Future Prospects for Leading Companies

出版商 Visiongain Ltd 商品編碼 206682
出版日期 內容資訊 英文 222 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥品的凍結乾燥:產品及服務 Lyophilisation for Pharmaceuticals - Products and Services 2015-2025: Future Prospects for Leading Companies
出版日期: 2015年01月16日 內容資訊: 英文 222 Pages
簡介

全球冷凍乾燥市場收益預計2015年達到34億5,000萬美元。在已開發國家及發展中國家中,冷凍乾燥技術與服務有許多相關的商業機會。

本報告提供藥品的凍結乾燥市場相關調查、未來的銷售額預測、各國趨勢、市場機會、各次級市場趨勢,及參與企業簡介彙整。

第1章 報告概要

第2章 冷凍乾燥的簡介

  • 冷凍乾燥市場概要
  • 冷凍乾燥的恩惠
  • 冷凍乾燥設備的基本
  • 冷凍乾燥流程
  • 冷凍乾燥技術的目前因素
  • 醫藥品、生物科技產業的冷凍乾燥
  • 花費費用的技術
  • 食品及醫藥品的冷凍乾燥
  • 冷凍乾燥技術產業及市場的課題
  • 冷凍乾燥相關法規
  • 冷凍乾燥技術與服務市場區隔

第3章 冷凍乾燥技術及服務:全球市場

  • 本報告的範圍
  • 全球冷凍乾燥市場
  • 全球冷凍乾燥產品及服務:市場區隔
  • 主要的冷凍乾燥產品
  • 冷凍乾燥技術與服務市場;銷售額預測
  • 有最大潛力的是哪個冷凍乾燥市場區隔

第4章 主要冷凍乾燥市場

  • 各地區明細
  • 各地區預測
  • 全球市場佔有率
  • 全球法律規章
  • 美國
  • 歐洲主要5個國家
  • 日本
  • 金磚四國
  • 中國
  • 印度
  • 俄羅斯
  • 巴西
  • 墨西哥、韓國、土耳其

第5章 到2025年為止的主要用途

  • 治療領域
  • 主要的應用
  • 主要的部門組合
  • 各用途市場預測
  • 主要治療層級的收益預測

第6章 主要企業

  • 細分的產業
  • 主要的冷凍乾燥企業
    • SP Specific
    • GEA Pharma Systems
    • Labconco Corporation
    • IlShinBioBase
    • IMA Life
    • Martin Christ Gefriertrocknungsanlagen GmbH
  • 主要的消耗品供應商
  • 主要的醫藥品受託製造廠商
    • Boehringer Ingelheim
    • Pantheon
    • Baxter BioPharma Solutions
    • Recipharm
    • IDT Biologika GmbH
    • Vetter Pharma-Fertigung

第7章 冷凍乾燥技術市場定性分析

  • SWOT分析
  • 促進因素與阻礙因素
  • Pestel分析
  • 波特的五力分析

第8章 專家的意見

第9章 結論

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0021

What are the commercial prospects for pharmaceutical freeze-drying? Visiongain's brand new report gives you revenue predictions for the lyophilisation for pharmaceuticals market and its submarkets to 2025, helping you stay ahead.

The 222-page report provides 142 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, drivers and restraints, and revenue predictions.

Besides revenue forecast to 2025, this report provides you with market shares, business outlooks, qualitative analyses (including SWOT, PESTEL Analysis and Porter's Five Forces Analysis), company profiles and commercial developments. Also, read full transcripts of expert opinion interviews informing you about new lyophilisation technologies and the types of products that tend to be lyophilised:

  • Dr Steven Nail, Principle Scientist, Baxter Medical Products R&D
  • Enrico Corona, Formulation and Process Development Manager, Patheon Italia (Ferentino site)
  • Scott Goldstein, Senior Manager at Fill-finish, Ajinomoto Althea

Discover sales predictions for the overall lyophilisation for pharmaceuticals market and the major Submarkets

In addition to analyses of the overall world market, you will see revenue forecasting of four world-level submarkets to 2025:

  • cGMP lyophilisers
  • Laboratory lyophilisers
  • Lyophilisation services
  • Others

This will give you insight into the leading Lyophilisation Products and Services market and their growth potential over the forecast period.

Find out the Prospects for Leading Therapeutic Applications

Also, you will see how eight drug classes using freeze drying technology will perform to 2025:

  • Therapeutic monoclonal antibodies (mAbs)
  • Insulins
  • Interferons
  • Other recombinant hormones
  • Plasma and recombinant coagulation factors
  • Biosimilars
  • Vaccines
  • Other therapeutic proteins

Our investigation shows business research and analysis with individual revenue forecasts and discussions. Use our predictions to help expand your business and you more influence. You will receive the forecasting leaders need.

What are the prospects in leading regions and countries?

The regional demand for lyophilisation products and services is expanding particularly in emerging markets. However, many commercial opportunities remain for lyophilisation technologies and services in developed countries as well.

Our analyses show you individual revenue forecasts to 2025 for 14 national markets:

  • US
  • Japan
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • China
  • Brazil
  • Russia
  • India
  • Mexico
  • South Korea
  • Turkey
  • RoW

New biological drugs and vaccines will benefit regional and national markets for those pharmaceutical drying technologies.

Leading companies and potential for market growth

Overall world revenue for the lyophilisation market will reach $3.45bn in 2015, our study forecasts. We predict greater demand for lyophilisation products and services over the forecast period, with equipment providers and CMOs providing lyophilisation services expanding to meet these market needs. Our work shows you which lyophilisation equipment and service providers hold greatest potential. See profiles of 12 leading companies:

  • SP Scientific
  • GEA Lyophil GmbH
  • Labconco Corporation
  • IIShinBioBase
  • IMA Life
  • Martin Christ Gefriertrocknungsanlagen GmbH
  • Boehringer Ingelheim BioXcellence
  • Pantheon
  • Baxter BioPharma Solutions
  • Recipharm
  • IDT Biologika GmbH
  • Vetter Pharma-Fertigung

In general, a company profile gives you the following information:

  • Historical and recent financial results
  • Discussion of a company's activities and outlook
  • Assessment of recent developments - mergers and acquisitions (M&A), new products and service offerings, collaborations, including alliances, partnerships and joint ventures.

What affects the Lyophilisation for Pharmaceuticals Products and Services Market?

Our study lets you assess the current issues and driving trends in the lyophilisation products and services market. You will find discussions, including qualitative analyses:

  • The growing market for biopharmaceutical products, with many biopharmaceutical categories growing rapidly
  • Emerging new technologies for drying and preserving pharmaceuticals including controlled ice nucleation
  • Injectable solutions, therapeutic proteins, peptides, vaccines and other aspects of biopharmaceutical production.
  • Increasing demand for parenteral drugs.

How the Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies report helps you

In summary, our 222-page report gives you the following knowledge:

  • Revenue forecast to 2025 for the world market and 4 submarkets - Discover the industry's prospects, finding promising places for investment and revenues.
  • Revenue forecasts to 2025 for the leading 14 national markets - US, Japan, Germany, France, UK, Italy, Spain, Brazil, Russia, China, India, Turkey, South Korea, Mexico and RoW
  • Assessment of 12 leading companies - hear about lyophilisation for pharmaceuticals products and technologies, results and strategies
  • Review of R&D pipelines - investigate developmental trends and progress
  • Analysis of what stimulates and restrains that industry and market - assess competitive technologies as well as major drivers for lyophilisation products and services, helping you compete and get advantages.
  • View opinions from our survey, seeing interviews with leading experts.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our study you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the lyophilisation products and services market and leading companies. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. The Lyophilisation for Pharmaceuticals Overview
  • 1.2. Lyophilisation Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Reports
  • 1.10. About Visiongain

2. Introduction to Lyophilisation (Freeze Drying)

  • 2.1. Lyophilisation Market Overview
  • 2.2. The Benefits of Lyophilisation
  • 2.3. Freeze Drying Equipment
  • 2.4. The Freeze Drying Process
  • 2.5. Current Components in Freeze Drying Technology
    • 2.5.1. Critical Parameters in the Lyophilisation Process
    • 2.5.2. The Stages in the Lyophilisation Process
      • 2.5.2.1. STAGE 1: Freezing
      • 2.5.2.2. STAGE 2: Primary Drying (Sublimation)
      • 2.5.2.3. STAGE 3: Secondary Drying (Desorption)
    • 2.5.3. Freeze Dried Products Characteristics
      • 2.5.3.1. Challenges Associated with Freeze Drying
  • 2.6. Lyophilisation: An Expensive Process
    • 2.6.1. The Biological Market: Proportion of Lyophilisation (%)
    • 2.6.2. Main Applications of the Lyophilisation Technology
    • 2.6.3. Lyophilisation: Market Shares (%) for Different Sectors
    • 2.6.4. Challenges for Freeze Drying Technology
    • 2.6.5. Scale-up Stage for Lyophilised Products
    • 2.6.6. Main Issues at Large-Scale Production Stage for Lyophilised Products
    • 2.6.7. Main Challenges in a Freeze Drying Plant
    • 2.6.8. Main Issues in Production
    • 2.6.9. Deficiencies in a Freeze Drying Process
  • 2.7. Challenges Facing the Lyophilisation Technology Industry and Market
  • 2.8. Lyophilisation Regulations: Current Good Manufacturing Practices (cGMP) and Quality by Design (QbD)
  • 2.9. Lyophilisation Products and Services Market Segmentation
    • 2.9.1. cGMP Lyophilisers
    • 2.9.2. Laboratory Lyophilisers
    • 2.9.3. Lyophilisation Services

3. Lyophilisation Products and Services: World Market 2015-2025

  • 3.1. Scope of this Report
  • 3.2. The World Lyophilisation Market, 2013-2014
  • 3.3. Lyophilisation Products and Services Market Segmentation, 2013-2014
  • 3.4. Leading Lyophilised Products, 2015
  • 3.5. World Lyophilisation Technology and Services Market: Sales Forecast 2015-2025
  • 3.6. Leading Segments for the Lyophilisation Technology and Services: Sales Forecasts 2015-2025
    • 3.6.1. The World Lyophilisation Market: Submarkets
    • 3.6.2. The Changing Market Shares of the Leading Lyophilisation Submarkets, 2015-2025
    • 3.6.3. Lyophilisation Products and Services: CAGR 2013-2025 by Segment
  • 3.7. Market Opportunities in the Lyophilisation Products and Services Market, 2015-2025
    • 3.7.1. The cGMP Lyophilisers Sales Forecast, 2015-2025
    • 3.7.2. The Laboratory Lyophilisers Sales Forecast, 2015-2025
    • 3.7.3. The Lyophilisation Services Sales Forecast, 2015-2025
    • 3.7.4. Lyophilisation: Drivers and Restraints 2015-2025

4. Leading National Lyophilisation Markets 2015-2025

  • 4.1. Regional Breakdown of the World Lyophilisation Products and Services Market, 2013-2014
  • 4.2. World Lyophilisation Products and Services Market: Regional Forecasts 2015-2025
  • 4.3. The Market Shares of the World Lyophilisation Products and Services Market, 2015-2025
  • 4.4. Global Regulations for Lyophilisation Products and Services
  • 4.5. The US Lyophilisation Products and Services Market Sales Forecast, 2015-2025
    • 4.5.1. US Lyophilisation Products and Services Market: Leading Companies in the US, 2015
    • 4.5.2. The US Keeps Dominating the Lyophilisation Products and Services Market
    • 4.5.3. Healthcare Expenditure in the US
    • 4.5.4. US Lyophilisation Products and Services Market: Drivers and Restraints
  • 4.6. The Lyophilisation Products and Services Market in the Five Leading European National Markets (EU5), 2015-2025
    • 4.6.1. The Changing Market Shares of the EU5 Lyophilisation Products and Services Market
      • 4.6.1.1. The German Lyophilisation Products and Services Market Sales Forecast, 2015-2025
      • 4.6.1.2. The French Lyophilisation Products and Services Market Sales Forecast, 2015-2025
      • 4.6.1.3. The Italian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
      • 4.6.1.4. The Spanish Lyophilisation Products and Services Market Sales Forecast, 2015-2025
      • 4.6.1.5. The UK Lyophilisation Products and Services Market Sales Forecast, 2015-2025
  • 4.7. The Japanese Lyophilisation Products and Services Market Sales Forecast, 2015-2025
  • 4.8. The BRIC Nations Lyophilisation Products and Services Market Sales Forecast, 2015-2025
    • 4.8.1. The BRIC Nations: Drivers and Restraints 2015-2025
  • 4.9. The Chinese Lyophilisation Products and Services Market 2015-2025: Overview
    • 4.9.1. Freeze-Drying Companies Based in China
    • 4.9.2. The Chinese Lyophilisation Products and Services Market Sales Forecast, 2015-2025
  • 4.10. The Indian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
  • 4.11. The Russian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
  • 4.12. The Brazilian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
  • 4.13. The Mexican, South Korean and Turkish (MKT) Lyophilisation Products and Services Markets: the New Emerging Economies
    • 4.13.1. The Mexican Lyophilisation Products and Services Market Sales Forecast, 2015-2025
    • 4.13.2. The South Korean Lyophilisation Products and Services Market Sales Forecast, 2015-2025
    • 4.13.3. The Turkish Lyophilisation Products and Services Market Sales Forecast, 2015-2025

5. Lyophilised Products by Global Leading Applications 2015-2025

  • 5.1. Growth Opportunities for the Lyophilisation Market: Therapeutic Areas
  • 5.2. Leading Applications 2015-2025
  • 5.3. Leading Sector Portfolios: Revenues by Sector 2013-2014
  • 5.4. Lyophilisation Market Forecast by Application Sector 2015-2025
  • 5.5. Lyophilised Drugs: Market Growth 2015-2025
  • 5.6. The Monoclonal Antibodies Market Sales Forecast, 2015-2025
    • 5.6.1. Monoclonal Antibodies: Drives the Use of Lyophilisation Technology and Services
  • 5.7. The Human Insulin Market Sales Forecast, 2015-2025
  • 5.8. The Interferon Market Sales Forecast, 2015-2025
    • 5.8.1. Interferons: Leading Lyophilised Products
  • 5.9. Other Recombinant Hormones Market Sales Forecast, 2015-2025
    • 5.9.1. Erythropoietins: A Market in Decline
    • 5.9.2. Granular-Colony Stimulating Factors (G-CSF): Cost-Effective Products
  • 5.10. The Plasma and Recombinant Coagulating Factors Market Sales Forecast, 2015-2025
    • 5.10.1. Leading Plasma and Recombinant Coagulating Factor Products, 2015
  • 5.11. Other Protein Therapeutics Market Sales Forecast, 2015-2025
    • 5.11.1. Other Protein Therapeutics Products, 2015
  • 5.12. The Biosimilars Market Sales Forecast, 2015-2025
    • 5.12.1. Biosimilars: Leading Products, 2015
  • 5.13. The Vaccines Market Sales Forecast, 2015-2025
    • 5.13.1. Top 10 Leading Vaccines in the Market, 2015
    • 5.13.2. Leading Lyophilised Vaccines, 2015
  • 5.14. Conclusion: Leading Applications of Lyophilisation Products and Services

6. Leading Companies in the Lyophilisation Industry Market, 2015

  • 6.1. The Lyophilisation Industry: Highly Fragmented
  • 6.2. Leading Equipment Providers
    • 6.2.1. Leading Equipment Providing Organisations
      • 6.2.1.1. SP Scientific
        • 6.2.1.1.1. SP Scientific: Overview and Global Presence
        • 6.2.1.1.2. SP Scientific: Lyophilisation Products Portfolio
        • 6.2.1.1.3. SP: Recent Developments
        • 6.2.1.1.4. Recent Acquisition: Bel-Art Products
        • 6.2.1.1.5. SP Scientific: Lyophilisation Services Portfolio
      • 6.2.1.2. GEA Lyophil (Part of GEA Pharma Systems)
        • 6.2.1.2.1. GEA Lyophil GmbH: Lyophilisation Products Portfolio
        • 6.2.1.2.2. GEA Lyophil GmbH: Lyophilisation Services Portfolio
      • 6.2.1.3. Labconco
        • 6.2.1.3.1. Labconco Corporation: Overview and Global Presence
        • 6.2.1.3.2. Labconco Corporation: Lyophilisation Products Portfolio
        • 6.2.1.3.3. Labconco Corporation: Lyophilisation Service Offerings
      • 6.2.1.4. IIShinBioBase
        • 6.2.1.4.1. IlShinBioBase: Overview and Global Presence
        • 6.2.1.4.2. Recent Developments
        • 6.2.1.4.3. IIShinBioBase: Lyophilisation Products Portfolio, 2015
        • 6.2.1.4.4. IlShinBioBase: Lyophilisation Services Portfolio, 2015
      • 6.2.1.5. IMA Life
        • 6.2.1.5.1. Recent Pharmaceutical Revenue and Financial Performance, 2012-2013
        • 6.2.1.5.2. IMA Life: Lyophilisation Products, 2015
        • 6.2.1.5.3. IMA Life: Lyophilisation Services Portfolio
        • 6.2.1.5.4. ICE FOG Nucleation Process
      • 6.2.1.6. Martin Christ Gefriertrocknungsanlagen GmbH
        • 6.2.1.6.1. Continuous Freeze Drying Operating Systems
        • 6.2.1.6.2. Martin Christ: Services, 2015
  • 6.3. Leading Consumables Providers
  • 6.4. Leading Contract Manufacturing Organisations (CMOs) for Lyophilisation Services
    • 6.4.1. Boehringer Ingelheim BioXcellence
      • 6.4.1.1. Boehringer Ingelheim BioXcellence: Overview and Global Presence
      • 6.4.1.2. Recent Financial Performance, 2012-2013
      • 6.4.1.3. Contract Manufacturing: Cost Cutting Initiative
      • 6.4.1.4. Boehringer Ingelheim BioXcellence: Prodigious Track Record
      • 6.4.1.5. Boehringer Ingelheim BioXcellence: Service Portfolio
      • 6.4.1.6. Boehringer Ingelheim Expands Biopharmaceuticals in China
    • 6.4.2. Pantheon
      • 6.4.2.1. Pantheon: Lyophilisation Capabilities, 2015
      • 6.4.2.2. Quality Standards
    • 6.4.3. Baxter BioPharma Solutions
      • 6.4.3.1. Baxter BioPharma Solutions: Lyophilisation Center for Excellence
      • 6.4.3.2. Baxter BioPharma Expansion
    • 6.4.4. Recipharm
      • 6.4.4.1. Revenue and Recent Performance Analysis, 2013
      • 6.4.4.2. Recipharm: Lyophilisation Capabilities
      • 6.4.4.3. Investment in Lyophilisation
    • 6.4.5. IDT Biologika GmbH
      • 6.4.5.1. Sterile Dosage Filling Capabilities: Expertise in Lyophilisation
      • 6.4.5.2. Facility Expansion
    • 6.4.5. Vetter Pharma-Fertigung: Overview and Global Presence
      • 6.4.5.1. Vetter Pharma-Fertigung: Service Offerings
      • 6.4.5.2. Vetter Pharma-Fertigung: Development Pipeline
      • 6.4.5.3. Vetter Development Services, 2015
      • 6.4.5.4. Vetter Commercial Manufacturing
      • 6.4.5.5. Vetter Packaging Solutions
      • 6.4.5.6. Vetter Answers: Specialist Knowledge
      • 6.4.5.7. Vetter Pharma-Fertigung: Lyophilisation Products
      • 6.4.5.8. Recent Developments: Drastically Increasing Capacity Size

7. Qualitative Analysis of the Lyophilisation Products and Services Market, 2015-2025

  • 7.1. SWOT Analysis of the Lyophilisation for Pharmaceuticals: Products and Services market
    • 7.1.2. Strengths
      • 7.1.2.1. Increasing Stability and Shelf life of Pharmaceuticals: Essential Technology for Healthcare
      • 7.1.2.2. Ease of Reconstitution
      • 7.1.2.3. Ease of Transport
    • 7.1.3. Weaknesses
      • 7.1.3.1. High Set-Up Costs
      • 7.1.3.2. Complex Technology and Process
      • 7.1.3.3. Slow Process
      • 7.1.3.4. High Running Costs
      • 7.1.3.5. Unoptimised Lyophilisation Cycle Development
    • 7.1.4. Opportunities
      • 7.1.4.1. Growing market in Pharmaceutical Therapeutics including Injectable Solutions, Proteins, Peptides and Vaccines
      • 7.1.4.2. High and Growing Demand for Product and Services in the Lyophilisation Field
      • 7.1.4.3. Ageing population
    • 7.1.5. Threats
      • 7.1.5.1. Stringent Regulation for Manufacturing Pharmaceuticals
      • 7.1.5.2. Competition of Alternative Methods of Drying
  • 7.2. Drivers and Restraints for the Lyophilisation Products and Services Market
  • 7.3. The PESTEL Analysis of the Lyophilisation: Products and Services Market
    • 7.3.1. Political Factors
    • 7.3.2. Economic Factors
    • 7.3.3. Socio-Cultural Factors
    • 7.3.4. Technological Factors
    • 7.3.5. Environmental Factors
    • 7.3.6. Legal Factors
  • 7.4. Porter's 5 Analysis of the Lyophilisation for Pharmaceuticals Market
    • 7.4.1. Rivalry Among Competitors [High]
    • 7.4.2. Threat of New Entrants [Low]
    • 7.4.3. Power of Suppliers [High]
    • 7.4.4. Power of Buyers [High]
    • 7.4.5. Threats of Substitutes [Medium]
      • 7.4.5.1. The Spray Drying Method
      • 7.4.5.2. Roche's Precipitation Method
      • 7.4.5.3. Vertical Integration With Technology Suppliers and Buyers

8. Expert Opinions

  • 8.1. Interview with Dr. Steven Nail, Principle Scientist, Baxter Medical Products R&D
    • 8.1.1. Big and Small Pharma Outsource Lyophilisation
    • 8.1.2. A Graphic Approach to Freeze-drying Optimisation
    • 8.1.3. Lyophilisation: Recent Technology and Developments
    • 8.1.4. Protein Based Pharmaceuticals and Lyophilisation
    • 8.1.5. CMOs: In-house or Outsourcing Trend?
    • 8.1.6. R&D Key Areas
    • 8.1.7. Baxter Biopharma Solution: Freeze-Drying Capabilities
  • 8.2. Enrico Corona, Formulation and Process Development Manager, Patheon Italia (Ferentino site)
    • 8.2.1. Big and Small Pharma: Use CMOs to Facilitate Lyophilisation
    • 8.2.2. Pantheon has Preclinical and Clinical Lyophilisation Capabilities
    • 8.2.3. Lyophilisation is An Improving Process
    • 8.2.4. Biopharmaceutical Demands For Lyophilisation Services
    • 8.2.5. Lyophilisation Capacity is not Keeping Up with Demand
    • 8.2.6. Major Lyophilisation Class: Recombinant Protein Drugs
    • 8.2.7. Scaling Up the Freeze-drying Process
    • 8.2.8. Technology and Development
  • 8.3. Scott Goldstein, Senior Manager at Fill-finish, Ajinomoto Althea
    • 8.3.1. Demand for Lyophilisation in Earlier Clinical Trials
    • 8.3.2. Flexibility Required for Different Batch Sizes
    • 8.3.3. The Challenge of Scaling Up the Lyophilisation Process
    • 8.3.4. Big Pharma Outsource Clinical Batch Work
    • 8.3.5. Growing Number of Drugs Are being Lyophilised

9. Conclusions

  • 9.1. Rapid growth in the Lyophilisation Products and Services Market: 2015-2025
  • 9.2. Lyophilisation Services is the Leading Submarket, 2013-2014
  • 9.3. World Lyophilisation Products and Services: Regional Markets
  • 9.4. Revenue Growth of Applications using the Lyophilisation Products and Services Market
  • 9.5. Leading Lyophilisation Products and Services Companies
  • 9.6. Drivers for the Lyophilisation Product and Services Market
  • 9.7. Restraints for the Lyophilisation Product and Services Market
  • 9.8. Concluding Remarks

List of Tables

  • Table 1.1: World Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Submarket, 2013-2025
  • Table 3.1: Market Size ($bn) and Market Shares (%) for Lyophilisation Products and Services Submarkets, 2013
  • Table 3.2: Projected Market Size ($bn) and Market Shares (%) for Lyophilisation Products and Services Submarkets, 2014
  • Table 3.3: World Lyophilisation Technology and Services Market Forecast: Revenues ($bn) and AGR (%) by Segments, 2013-2014
  • Table 3.4: Prefilled Syringes for Lyophilised Drugs, 2015
  • Table 3.5: Leading Lyophilised Drugs, 2015
  • Table 3.6: The Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 3.7: The Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Submarket, 2013-2025
  • Table 3.8: Market Shares (%) of the Lyophilisation Products and Services Submarkets, 2013, 2019 and 2025
  • Table 3.9: The Lyophilisation Products and Services Market: CAGR (%) by Segment, 2013-2019, 2019-2025 and 2013-2025
  • Table 3.10: The cGMP Lyophilisers Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 3.11: The Laboratory Lyophilisers Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 3.12: The Lyophilisation Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.1: The Lyophilisation Products and Services Market: Revenue ($bn), Market Share (%), 2013-2014
  • Table 4.2: The Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.3: Lyophilisation Products and Services Market: Shares (%) by Region, 2013, 2019 and 2025
  • Table 4.4: The US Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.5: Top 40 Freeze Drying Companies in the US, 2015
  • Table 4.6: The EU5 Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.7: The EU5 Lyophilisation Products and Services Market Forecast: Market Shares (%) by National Market, 2013, 2019, 2025
  • Table 4.8: Selected Companies Based in Europe, 2015
  • Table 4.9: The German Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.10: The French Lyophilisation Product and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.11: The Italian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.12: The Spanish Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.13: The UK Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.14: The Japanese Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.15: The BRIC Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.16: Lyophilisation Companies in China, 2015
  • Table 4.17: The Chinese Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.18: The Indian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.19: The Russian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.20: The Brazilian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.21: The Mexican Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.22: The South Korean Lyophilisation Products and Services Market Sales Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 4.23: The Turkish Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 5.1: Leading Biopharmaceutical Sectors by Revenue Size ($bn) , 2013-2014
  • Table 5.2: Leading Therapeutics Proteins Submarkets by Revenue Size ($bn) , Market Share (%), 2013-2014
  • Table 5.3: Leading Application Sectors in the Lyophilisation Market: Revenues ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 5.4: The Monoclonal Antibodies Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 5.5: Leading Lyophilised Monoclonal Antibodies, 2014
  • Table 5.6: The Insulin Market Forecast: Sales Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 5.7: The Interferon Market Forecast: Sales Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 5.8: Leading Lyophilised Interferon Drugs, 2015
  • Table 5.9: Other Recombinant Hormones Market Forecast: Revenue ($bn), AGR (%),CAGR (%), 2013-2025
  • Table 5.10: Plasma and Recombinant Coagulating Factors Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2013-2025
  • Table 5.11: Leading Plasma and Recombinant Coagulating Factors Products, 2015
  • Table 5.12: Other Protein Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2013-2025
  • Table 5.13: Other Protein Therapeutics Lyophilised Products, 2015
  • Table 5.14: The Biosimilars Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2013-2025
  • Table 5.15: Leading Biosimilar Products, 2015
  • Table 5.16: The Vaccines Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2013-2025
  • Table 5.17: Top 10 Leading Vaccine Products by Revenue ($bn), 2013
  • Table 5.18: Prominent Lyophilised Vaccines, 2015
  • Table 6.1: Companies Providing Freeze Dryers and Associated Systems to the Pharmaceutical Industry, 2015
  • Table 6.2: SP Scientific Lyophilisation Products, 2015
  • Table 6.3: SP Scientific Lyophilisation Services, 2015
  • Table 6.4: GEA Lyophil GmbH Products, 2015
  • Table 6.5: GEA Lyophil GmbH Services, 2015
  • Table 6.6: Labconco Corporation Lyophilisation Products, 2015
  • Table 6.7: Labconco Corporation Lyophilisation Services, 2015
  • Table 6.8: IIShinBioBase Lyophilisation Products, 2015
  • Table 6.9: IIShinBioBase Lyophilisation Services, 2015
  • Table 6.10: IMA Life Lyophilisation Products, 2015
  • Table 6.11: IMA Life Service Offerings, 2015
  • Table 6.12: Martin Christ Lyophilisation Products, 2015
  • Table 6.13: Martin Christ Lyophilisation Services, 2015
  • Table 6.14: Leading Manufacturers of Vials Suitable for Lyophilisation Processes, 2015
  • Table 6.15: CMOs Providing Lyophilisation Services, 2015
  • Table 6.16: Boehringer Ingelheim BioXcellence Product Track Record, 2015
  • Table 6.17: Boehringer Ingelheim BioXcellence Services, 2015
  • Table 6.18: Vetter Pharma-Fertigung Lyophilisation Service Offerings, 2015
  • Table 6.19: Vetter Products, 2015
  • Table 7.1: SWOT Analysis of the Lyophilisation Products and Services Market, 2015-2025
  • Table 7.2: Lyophilisation Technology and Spray Drying Technology, 2015

List of Figures

  • Figure 1.1: Lyophilisation Products and Services Market: Overview of Submarkets and Segments
  • Figure 1.2: Lyophilisation Products and Services Market: Shares (%) by Region, 2014
  • Figure 2.1: Lyophilisation Equipment Model
  • Figure 2.2: Current Components in the Freeze Drying Technology, 2015
  • Figure 2.3: Stages in the Lyophilisation Process
  • Figure 2.4: The Biologics Market: Proportion (%) of Lyophilised Products, 2014
  • Figure 2.5: Market Shares (%) for Dosage Forms of Biopharmaceuticals, 2014
  • Figure 2.6: Market Shares (%) of Freeze Dried Systems by Industry, 2014
  • Figure 3.1: World Lyophilisation Market Shares (%) by Leading Categories, 2013
  • Figure 3.2: Projected World Lyophilisation Market Shares (%) by Leading Categories, 2014
  • Figure 3.3: Projected World Lyophilisation Market Size ($bn) by Leading Categories, 2013 and Forecasted 2014
  • Figure 3.4: The Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 3.5: The Lyophilisation Products and Services Market Forecast: Revenue ($bn), 2013-2025
  • Figure 3.6: The Lyophilisation Products and Services market: Market Shares (%) by Submarket, 2019
  • Figure 3.7: The Lyophilisation Products and Services market: Market Shares (%) by Submarket, 2025
  • Figure 3.8: The Lyophilisation Products and Services Market, CAGR (%) by Segment, 2013-2019
  • Figure 3.9: The Lyophilisation Products and Services Market, CAGR (%) by Segment, 2019-2025
  • Figure 3.10: The Lyophilisation Products and Services Market, CAGR (%) by Segment, 2013-2025
  • Figure 3.11: The Lyophilisation Products and Services Market Forecast: Opportunities by Segment, 2013-2025
  • Figure 3.12: The cGMP Lyophilisers Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 3.13: The Laboratory Lyophilisers Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 3.14: The Lyophilisation Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 3.15: Lyophilisation Products and Services Market: Drivers and Restraints, 2015-2025
  • Figure 4.1: Lyophilisation Products and Services Market: Shares (%) by Region, 2013
  • Figure 4.2: Lyophilisation Products and Services Market: Shares (%) by Region, 2014
  • Figure 4.3: Lyophilisation Products and Services Market: Shares (%) by Region, 2019
  • Figure 4.4: Lyophilisation Products and Services Market: Shares (%) by Region, 2025
  • Figure 4.5: The US Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.6: The US Lyophilisation Products and Services Market: Drivers and Restraints, 2015-2025
  • Figure 4.7: The EU5 Lyophilisation Products and Services Market: Market Shares (%) by National Market, 2013
  • Figure 4.8: The EU5 Lyophilisation Products and Services Market: Market Shares (%) by National Market, 2019
  • Figure 4.9: The EU5 Lyophilisation Products and Services Market: Market Shares (%) by National Market, 2025
  • Figure 4.10: The German Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.11: The French Lyophilisation Product and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.12: The Italian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.13: The Spanish Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.14: The UK Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.15: The Japanese Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.16: The BRIC Nations Lyophilisation Products and Services Market Forecast ($bn) by Country, 2013-2025
  • Figure 4.17: The BRIC Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.18: The BRIC Nations: Drivers and Restraints, 2015-2025
  • Figure 4.19: The Chinese Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.20: The Indian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.21: The Russian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.22: The Brazilian Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.23: The Mexican Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.24: The South Korean Lyophilisation Products and Services Market Sales Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 4.25: The Turkish Lyophilisation Products and Services Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.1: The Monoclonal Antibodies Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.2: The Insulin Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.3: The Interferons Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.4: Other Recombinant Hormones Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.5: Plasma and Recombinant Coagulating Factors Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.6: Other Protein Therapeutics Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.7: The Biosimilars Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.8: The Vaccines Market Forecast: Revenue ($bn), AGR (%), 2013-2025
  • Figure 5.9: Top Therapy Classes: World Revenue ($bn) 2013, 2025, CAGR (%), 2013-2025
  • Figure 6.1: IMA Life: Pharmaceutical Revenue ($m), 2012-2013
  • Figure 6.2: Boehringer Ingelheim: Biopharmaceuticals Revenue ($m), 2012-2013
  • Figure 6.3: Recipharm: Revenue ($m), 2012-2013
  • Figure 6.4: Vetter Pharma-Fertigung: Development Pipeline 2015
  • Figure 7.1: Lyophilisation Products and Services Market: Drivers and Restraints, 2015-2025
  • Figure 7.2: Porter's Five Analysis of the Lyophilisation Products and Services Market, 2015-2025
  • Figure 9.1: Global Lyophilisation Products and Services Market: Revenue ($bn), 2015-2025
  • Figure 9.2: Global Lyophilisation Products and Services Market: Revenue ($bn) by Segment, 2013-2014
  • Figure 9.3: Global Lyophilisation Products and Services Market: Revenue ($bn) by Region, 2013 and 2025
  • Figure 9.4: Top Therapy Classes: World Revenue ($bn) 2013, CAGR (%), 2013-2025

Companies Listed

  • AAIPharma Services
  • ACMAS Technocracy
  • Affinity Life Sciences
  • Ajinomoto Althea
  • Albany Molecular Research Inc. (AMRI)
  • ALK-Abelló
  • Alliance Medical Products
  • Althea Technologies
  • Amgen
  • Anteco Pharma
  • Apex Lyo
  • Astellas Pharma
  • Baxter
  • Baxter BioPharma Solutions
  • Bayer
  • Beijing Sino-German Tianhe Technology (BSGT)
  • Beijing Suyuan Zhongtian Scientific Inc.
  • Bel-Art Products
  • Ben Venue Laboratories (a part of Boehringer Ingelheim)
  • Berna Biotech
  • Bilcare Global Clinical Supplies
  • Biogen Idec
  • Biolyph
  • Bio-Manguinhos Fiocruz
  • Biopartners
  • Biopharma Technology
  • BioVectra
  • Boehringer Ingelheim
  • Cangene bioPharma
  • CARBOGEN AMCIS
  • Catalent Pharma Solutions
  • Celltrion
  • Cephalon
  • Changzhou Yibu Drying Equipment Co.
  • CIMA Labs
  • CMC Biologics
  • Coldstream Laboratories
  • Cole-Parmer Instrument Company
  • Corden Pharma
  • CoreRx Pharmaceuticals
  • Creapharm
  • CSL Behring
  • CSL Biotherapies
  • CT Arzneimettel
  • Cuddon Freeze Dry
  • Dong-A-Pharm
  • DRAXIS Pharma General Partnership
  • DSM Pharmaceuticals
  • E.R. Squibb & Sons
  • Eli Lilly
  • EMS Serono
  • EnWave
  • Eurogentec
  • European Freeze Dry
  • Famar Health Care Services
  • Ferring Pharmaceuticals
  • Formatech
  • Freeze Dryer Systems Europe
  • Freezedry Specialties
  • Fresenius Kabi
  • Frozen In Time
  • FTS Systems
  • Gate Pharmaceuticals
  • GE Healthcare
  • GEA Lyophil
  • GEA Niro (a company of the GEA Group)
  • Genentech (Roche)
  • GeneScience
  • Genzyme (Sanofi)
  • GEO Lyophil (Beijing) Ltd.
  • Getz Pharma Research
  • GILYOS GmbH
  • GIPHARMA
  • Girindus (a member of Solvay Group)
  • Gland Pharma Limited
  • GlaxoSmithKline
  • GP Pharm
  • Grand River Aseptic Manufacturing
  • GSK
  • Haupt Pharma
  • Hexal
  • HollisterStier Laboratories (a Jubilant Life Sciences company)
  • Hosokawa Micron Powder Systems
  • Hospira
  • HTD Biosystems
  • Hull (a part of SP industries)
  • Human Genoma Sciences
  • I.M.A. Industria Macchine Automatiche
  • IDT Biologika
  • IIShinBioBase
  • IMA Life (Beijing) Pharmaceutical Systems Co., Ltd.
  • Intas Biophrmaceuticals
  • Intelligent Pharma
  • Irvine Pharmaceutical Services
  • Janssen Biotech
  • Janssen Cilag
  • JHP Pharmaceuticals
  • KP Pharmaceutical Technology
  • Labconco
  • Legacy Pharmaceuticals International
  • LG Life Sciences
  • LifeScientz Bio-tech Company
  • Lonza
  • Lyka Labs
  • Lyofal
  • Lyophilisation Systems Inc
  • Lyophilization Services of New England
  • Lyophilization Technology
  • Martin Christ Gefriertrocknungsanlagen
  • MechaTech Systems
  • Medice
  • Merck
  • Merck Sharp & Dohme Corporation
  • Merk Process
  • Millrock Technology
  • Miltenyi Biotec, Bioprocess Division
  • Nanjing Guyan Pharmaceutical Equipment Co.
  • Nextar Chempharma Solutions
  • NextPharma Technologies
  • Novartis
  • Novo Nordisk
  • Oakwood Laboratories
  • OctoPlus
  • One 2 One
  • Onko Koçsel
  • Optima Group Pharma
  • Oregon Freeze Dry
  • Organon Teknika (Merck)
  • Oso BioPharmaceuticals Manufacturing
  • Patheon
  • Peptisyntha (a part of Solvay Group)
  • Pfizer
  • Pfizer CentreSource (PCS)
  • Pharmatek Laboratories
  • PharmIdea
  • Piramal Pharma Solutions
  • Praxair Inc.
  • ProJect Pharmaceutics
  • Pyramid Laboratories
  • Quality BioResources
  • Quorum Technologies
  • Ratiopharm
  • Recipharm Cobra Bio
  • Regeneron Pharmaceuticals
  • Reig Jofre Group
  • Roch Mechatronics
  • Roche
  • SAFC
  • Sandoz (a Novartis company)
  • Sanofi
  • Schering-Plough
  • Serail
  • SGD Pharma
  • Shandong Weigao
  • Shanghai Far-East Pharmaceutical Machinery General Factory
  • Shanghai Findnovo Mechanical Technology Co.
  • Shanghai Medical Instrument Manufacturing Co.
  • Shanghai Pudong Freeze Dryer Equipment Co., Ltd.
  • Shanghai Suparnin Pharmaceutical Equipment Co., Ltd.
  • Shanghai Tofflon Science and Technology Co., Ltd.
  • Shanghai Yucheng Dryer Equipment Co.
  • SL Pharma Labs
  • SP Scientific
  • SPI Pharmaceuticals
  • Stada
  • Takeda
  • Talecris Biotherapeutics
  • Telstar
  • Teva
  • The University of Iowa Pharmaceuticals
  • Therapure Biopharma
  • Thermo Fisher Scientific
  • UCB
  • Unilife Corporation
  • UPM Pharmaceuticals, Inc.
  • USIFROID (a Telstar company)
  • Valeant Pharmaceuticals
  • Vetter Pharma- Fertigung
  • West Phamaceutical Services
  • Wheaton Sciences Products
  • Wockhardt
  • Wyeth (Pfizer)
  • Xcelience
  • Xellia Pharmaceuticals
  • Zhangjiang Biotech & Pharmaceutical Base Development Company
  • Zirbus Technology

Other Organisations Mentioned in This Report

  • European Medicines Agency (EMA)
  • Ministry for Health, Labour and Welfare (Japan)
  • State Children's Health Insurance Programme (SCHIP)
  • The European Commission (EC)
  • The Federal Food and Drug Association Modernisation Act (FDAMA)
  • The Food and Drug Administration (FDA) (US)
  • The Research Foundation for Microbial Diseases of Osaka University
  • The World Bank
  • United Nations (UN)
  • World Health Organization (WHO)
Back to Top